CCL2 and coronary artery disorder: In CAD, EAT acts as an endocrine and paracrine organ that could release proinflammatory mediators, such as TNF-α, interleukin-6, and monocyte chemoattractant protein-1, into adjacent coronary vessels, thereby promoting atherogenesis [7,19].